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Background: For peripheral artery disease (PAD), MR angiography (MRA) is a well-established diagnostic modality provid-
ing morphologic and dynamic information comparable to digital subtraction angiography (DSA). However, relatively large
amounts of contrast agents are necessary to achieve this.
Purpose: To evaluate the diagnostic accuracy of time-resolved 4D MR-angiography with interleaved stochastic trajectories
(TWIST-MRA) by using maximum intensity projections (MIPs) of dynamic images acquired with reduced doses of contrast
agent.
Study Type: Retrospective.
Population: Forty adult PAD patients yielding 1088 artery segments.
Field Strength/Sequence: A 3.0 T, time-resolved 4D MR-angiography with TWIST-MRA and MIP of dynamic images.
Assessment: DSA was available in 14 patients (256 artery segments) and used as reference standard. Three-segmental
MIP reconstructions of TWIST-images after administration of 3 mL of gadolinium-based contrast agent (Gadoteridol/
Prohance®, 0.5 M) per anatomical level (pelvis, thighs, and lower legs) yielded 256 artery segments for correlation between
MRA and DSA. Three independent observers rated image quality (scale: 1 [nondiagnostic] to 4 [excellent]) and the degree
of venous overlay (scale: 0 [none] to 2 [significant]) for all segments. Diagnostic accuracy for the detection of >50% stenosis
and artery occlusion was calculated for all observers.
Statistical Tests: Binary classification test (sensitivity, specificity, positive/negative predictive values, diagnostic accuracy).
Intraclass correlation coefficients (ICCs), logistic regression analysis with comparison of areas under the receiver-operating-
characteristics (ROC) curves (AUCs) with the DeLong method. Bland–Altman-comparison.
Results: High diagnostic performance was achieved for the detection of >50% stenosis (sensitivity 92.9% [84.3–99.9%
(95%-CI)] and specificity 98.5% [95.7–99.8% (95%-CI)]) and artery occlusion (sensitivity 93.1% [77.2–99.2% (95%-CI)] and
specificity 99.1% [96.9–99.9% (95%-CI)]). Inter-reader agreement was excellent with ICC values ranging from 0.95 to 1.0
for >50% artery stenosis and occlusion. Image quality was good to excellent for both readers (3.41  0.72, 3.33  0.65,
and 3.38  0.61 [mean  SD]) with good correlation between observer ratings (ICC 0.71–0.81). No significant venous over-
lay was observed (0.06  0.24, 0.23  0.43 and 0.11  0.45 [mean  SD]).
Data Conclusion: MIPs of dynamic TWIST-MRA offer a promising diagnostic alternative necessitating only reduced
amounts (50%) of gadolinium-based contrast agents for the entire runoff vasculature.
Evidence Level: 3
Technical Efficacy: Stage 2
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Peripheral artery disease (PAD) is a severe manifestation ofprimarily atherosclerotic artery disease with significant
clinical morbidity and mortality due to cardiovascular associ-
ated deaths.1,2
Digital subtraction angiography (DSA) is widely reg-
arded as the diagnostic reference standard primarily because
dynamic flow information is reliably obtained.3
However, its invasiveness and cost, as well as its require-
ment for ionizing radiation, have led to the development of
MR-angiography (MRA) as an alternative, either as a
multistation contrast-enhanced (ce) MRA or as a time-
resolved (TR) MRA. MRA has high diagnostic accuracy and
is often considered as the imaging modality of choice.4–6
Computed tomography angiography (CTA) is still reg-
arded as the quickest and most widespread imaging tool available
for evaluation of PAD, but its compromised diagnostic efficacy
due to atherosclerotic calcifications in small vessels and the lack
of dynamic flow information are well-known limitations.7
Evaluation of PAD with nonenhanced MRA tech-
niques, such as quiescient interval single-shot (QISS) MRA
unfortunately do not yield dynamic flow information and are
prone to venous overlay, especially in atherosclerotic small
vessels at the lower extremities.8–10 Dynamic flow analysis is
particularly important to assess the hemodynamic relevance of
stenoses, especially in smaller vessels, and unfortunately
motion artifacts, venous overlay and partial volume effects
often substantially limit diagnostic accuracy.11
Therefore, “hybrid MRA” that combines multistation
ce-MRA with TR-MRA has been established as the MRA
modality of choice. This has high diagnostic efficacy and
accuracy comparable to DSA and minimizes diagnostic pit-
falls such as venous overlay.12–15 However, dynamic flow
information with this approach is only acquired for the
infrapopliteal vessels and depending on inflow and col-
lateralization, venous overlay in ce-MRA can often occur.
A possible approach to solving this problem is “triple-
TWIST”MRA.16 This technique consists of a triple injection pro-
tocol for dynamic, high resolution, isotropic MRA of the entire
peripheral vascular system applying time-resolved 4D TWIST-
MRA sequences (time-resolved angiography with interleaved sto-
chastic trajectories). Thus, flow of the pelvic, thigh, and
infrapopliteal artery stations can be separately analyzed yielding
dynamic information of reduced or even reversed flow in each ana-
tomic region.16However, in a clinical study that adopted this tech-
nique at 1.5 T, relatively large amounts of the gadolinium-based
contrast agent (GBCA) gadobutrol (Gadovist®; Bayer Healthcare,
Germany) were used 1 M concentration, 15 mL total volume
applied, corresponding to 30 mL of a standard 0.5 M GBCA.
The authors acknowledged that a higher accumulative dose was
used than would ordinarily be needed for conventional ce-MRA
with gadobutrol necessitates.
Since controversy still surrounds the intracerebral reten-
tion of Gd following GBCA administration, and with emerging
evidence that Gd is retained to a certain extent in specific brain
areas after administration of all available GBCAs, new low-dose
approaches to MR imaging are desirable.17,18
MRA at higher magnetic field strengths such as 3 T yields
higher signal-to-noise ratio (SNR), thereby allowing shortening
of the acquisition time and improvement of spatial resolution
compared to that achievable at lower field strengths.19 Further-
more, the longer T1 relaxation times of stationary background
tissue at 3 T improve background tissue suppression which fur-
ther enhances contrast-to-noise.20 Consequently, higher field
strengths allow the amount of GBCA to be reduced without
substantial detriment to image quality.21
An additional practical problem of dynamic 4D MRA
sequences is the large amount of image data acquired. Reading
of all original image slices is laborious and time-consuming.
The purpose of this study was to evaluate the diagnostic
performance of a new low-dose approach in triple-TWIST
MRA at 3 T in patients with known or suspected PAD. Ini-
tially, to minimize reading time, only maximum intensity
projections (MIPs) of the source images were evaluated with




This retrospective study had institutional review board approval for
the image evaluation. Written clinical and research informed consent
was acquired for DSA and MRA from all patients.
From October 2017 to February 2019, 40 patients with
known PAD or symptoms of PAD underwent triple-TWIST MRA
and were included in this study.
Patient demographics are presented in Table 1.
Patient inclusion criteria were referral for suspected PAD and
feasibility of evaluation by MRA. Feasibility comprised immediate
availability of the MR scanner at our institution (7 AM to 22 PM,
Monday to Friday) and general patient compliance in terms of limb
pain attributed to possibly symptomatic PAD.
Exclusion criteria were common contraindications for MRA
such as pacemakers, cochlea ear implants, claustrophobia, pregnancy
as well as severe allergic predisposition to GBCA. Since this study
used a low-dose approach (9 mL total volume, corresponding to
~0.05 mmol/kg bodyweight in a 75 kg weighing patient), severely
impaired kidney function was not an exclusion criterion.22
Selective DSA was performed in 16 of these patients either as
a therapeutic interventional procedure or when MR angiograms
suggested pathologic conditions that warranted further investigation
(Fig. 1). Patients were referred for selective DSA no later than 5 days
after the MRA examination.
MR Imaging Protocol
Imaging was performed on a 3.0 T system (Magnetom VIDA®; Siemens
Healthineers, Erlangen, Germany, gradient strength 60 mT/m, slew rate
200 T/m/s). One flexible 18-channel phased-array radiofrequency
(RF) long body coil and a dedicated 36-channel peripheral vasculature
RF coil as well as a 32-channel RF spine array coil were used for data
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acquisition. All patients were placed in the supine position, feet first. An
18G i.v. access was placed in the left or right cubital vein.
Three anatomic levels (pelvis, thighs, and lower legs) were cov-
ered by acquisition of coronal 3D datasets after automatic contrast
injection, with slight overlap of the corresponding volumes.
Automatic injection (Accutron MR3, Medtron AG, Saa-
rbruecken, Germany) of GBCA was performed. A 3 mL volume of
gadoteridol (ProHance®, 0.5 M; Bracco Imaging, Milano, Italy) was
administered at 2.5 mL/sec for each anatomic level, followed by a
25 mL saline flush also at 2.5 mL/sec. Thus, a total cumulative vol-
ume of 9 mL (3 × 3mL) gadoteridol was administered per patient.
A modified time-resolved MRA sequence (TWIST; Siemens
Healthineers, Erlangen, Germany) was used for each anatomic area
(Table 2). This imaging sequence applies partial k-space
undersampling, with emphasis on more frequent sampling of the
center of k-space compared to the periphery of k-space (“key hole”
imaging). Missing data points in the peripheral k-space for each
sequential dataset are obtained from adjacent k-space intervals (“view
sharing”).23
In our modified protocol, sampling density was 15% for the
central k-space and 20% for the peripheral k-space, with variation of
peripheral k-space sampling trajectories throughout each sequential
measurement.24 Parallel acquisition (GRAPPA, acceleration factor
3 or 4) was applied and spatial resolution and coverage were adapted
for each station (see Table 2). By combining parallel acquisition with
TWIST-MRA, the resulting full 3D dataset was acquired with a
temporal resolution of 4.5 seconds. Acquisition of up to 20 sequen-
tial 3D datasets covered a time span of sequential measurements
with a temporal footprint of 12.7 seconds in the lower leg region.
For the pelvis and thigh regions, the temporal resolution per single
3D dataset was 2.32 seconds with a total of up to 16 sequential mea-
surements yielding a temporal footprint of 7.3 seconds.
Image acquisition was started 4 seconds–6 seconds before con-
trast administration. This ensured, that at least one unenhanced,
precontrast 3D dataset was obtained for each anatomic level, all-
owing for image subtraction using an unenhanced initial 3D dataset
as subtraction mask. Subsequently, dynamic subtracted 3D MIPs in
coronal orientation were created demonstrating the inflow of
TABLE 1. Patient demographics
Patient characteristics (n = 40)




Metal hip prosthesis 4 (10%)
Lower limb amputation 6 (15%)
AV-fistula 3 (7.5%)
Aortic stents 2 (5%)
Iliac artery stents 5 (12.5%)
Femoral artery stents 7 (17.5%)
Femoral popliteal bypass graft 2 (5%)
Mid aortic syndrome 1 (2.5%)
Entrapment of popliteal artery 1 (2.5%)
Numbers are either mean with range in parenthesis or total
numbers with % in parenthesis.
FIGURE 1: Flow chart of evaluation procedure
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contrast in the vessel territory of each anatomic level. Finally, static
3D MIP with maximum projection reconstructions (MPR)
(72 views, 5 steps of angulation) fusing all three anatomic levels
were generated to depict the entire runoff vasculature.
Digital Subtraction Angiography Protocol
Selective DSA was performed in 16 patients no later than 5 days
after the MRA study. Two experienced interventional radiologists
(A.M and P.M., with 15 years and 12 years of experience in inter-
ventional radiology, respectively) performed intra-arterial DSA as the
chosen reference standard (Artis Zee; Siemens Healthineers,
Erlangen, Germany). A common femoral artery approach was used
with a contralateral femoral retrograde access. A 4F Pigtail-catheter
was positioned either approximately 2 cm proximal to the bifurca-
tion of the infrarenal aorta or 2 cm proximal to the femoral bifurca-
tion. Angiograms of the symptomatic region in posterior–anterior
and angulated projections were obtained using 5 mL–10 mL of non-
ionic iodinated contrast medium (300 mg of iodine per milliliter;
Imeron 300, Bracco Imaging, Milano, Italy) per single DSA
(4 frames/sec in the pelvic region, 2 frames/sec in the upper leg
region, and 1 frame/sec in the lower leg region). The total amount
of iodine contrast agents administered ranged from 25 mL to –
75 mL per patient depending on the number of DSAs necessary.
Image Analysis
MR image data sets were displayed as dynamic, subtracted 3D MIP
images in random order, with all acquired sections provided. For
image analysis, the anatomic regions of arteries beginning at the
aorta just below the level of the renal arteries to the calves were
divided into 27 segments (Table 3). Three independent radiologists
(P.F., P.R. and T.W.; with 15, 6, and 5 years of experience in vascu-
lar imaging, respectively) independently evaluated all MRA images
using a dedicated PACS workstation (SECTRA IDS 7 workstation,
Sectra AB, Linkoeping, Sweden).
Initially, dynamic coronal MIP images were reviewed. Only if
questionable pathologic findings were seen, additional 3D MPR
images were analyzed. For imaging findings, deemed nondiagnostic
or inconclusive, the original source images were also made available
for review.
Reviewers rated overall image quality and arterial segment
depiction based on a 4-point Likert-Score (4, excellent image quality,
with enhancement allowing highly confident diagnosis; 3, good
image quality, with adequate enhancement for diagnosis; 2, fair
image quality, but still diagnostic; and 1, poor image quality, with
blurring of the arterial segment and nondiagnostic).25,26
In addition, venous contamination was rated using a three-
point scale (0, absence of venous overlay; 1, slight to moderate
venous overlay not compromising diagnostic confidence; and 2, sub-
stantial venous overlay impairing diagnostic confidence).
The grading system for severity of artery stenosis was adopted
from that used by the American College of Radiology for a multicen-
ter evaluation of MRA.27
The three readers reviewed the dynamic subtracted 3D MIP
images on a segment-by-segment basis and evaluated each arterial
segment in terms of hemodynamically relevant (>50%) artery steno-
sis or artery occlusion.
Minimal diameter stenosis (DS) values were measured by each
reader in the pelvic and thigh region.
Statistical Analysis
The findings from DSA and TR-MRA sequences were compared on
a segment by segment basis.
Positive and negative predictive values, sensitivity, specificity,
and overall diagnostic accuracy were calculated for the detection of
TABLE 2. Image Parameters of TWIST-MR Angiography for Three Anatomic Stations
Pelvis Thigh Lower legs
Voxel size (mm3) 1.3 × 1.3 × 2 1.3 × 1.3 × 2 1.3 × 1.3 × 1
Slices 56 56 64
3D block partial Fourier factor 6/8 6/8 6/8
TR (msec) 2.66 2.66 2.62
TE (msec) 0.92 0.92 0.95
Flip angle 17 17 25
Temp. resolution (seconds) 2.32 2.32 4.5
Temporal footprint (seconds) 7.26 7.26 12.7
Acquisition time (min:sec) 1:03 1:03 1:56
FOV (mm2) 500 × 437.5 500 × 437.5 500 × 437.5
GRAPPA imaging factor 4 4 3
Bandwidth (Hertz per pixel) 650 650 650
FOV = field of view; GRAPPA = generalized autocalibrating partially parallel acquisition.
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major (>50%) artery stenosis as well as artery occlusions using the
corresponding DSA images as reference standard. Corresponding
95% confidence intervals were provided for each diagnostic perfor-
mance evaluation. Areas under the receiver-operating-characteristic
(ROC) curves (AUC) were calculated for DS. Comparison of AUCs
was performed with the help of the DeLong test.
Inter-reader agreement of contingency analysis was determined
with the intraclass correlation coefficient (ICC) to determine inter-rater
reliability (two-way, mixed model, absolute agreement). ICC values less
than 0.5 are indicative of poor reliability, values between 0.5 and 0.75
indicate moderate reliability, values between 0.75 and 0.9 indicate good
reliability, and values greater than 0.90 indicate excellent reliability.
Image quality and venous overlay scores were summarized by
calculating means and standard deviations for each reader. Intraclass
correlation coefficients (ICCs) were calculated to assess correlation of
ratings between readers. Probability of true correlation in order to
reject the null hypothesis was evaluated by calculating P-values for
each correlation.
One-way analysis of variances (ANOVAs) with Bonferroni–Holm
correction was also performed to compare ratings between readers.
A P-value < 0.05 indicated statistical significance.
All statistical analyses were performed using commercially
available software (Prism® 7 for Windows, Version 7.00, GraphPad
Software Inc., San Diego, CA, USA and MedCalc Software Ltd.,
Version 19.6.4, Ostend, Belgium).
Results
Each reader evaluated 1088 segments across the 40 patients
that underwent MRA. All arterial segments were judged to be
sufficiently diagnostic (all image quality scores > 1).
Vessel segments with arterial stents, adjacent hip or knee
prostheses were poorly visualized because of susceptibility artifacts.
TABLE 3. Artery Segments Used for Image Analysis
Segment number with corresponding anatomic vascular
segment
1 Infrarenal aorta
2 Right common iliac artery
3 Left common iliac artery
4 Right external iliac artery
5 Left external iliac artery
6 Right common femoral artery
7 Left common femoral artery
8 Right proximal superficial femoral artery
9 Left proximal superficial femoral artery
10 Right distal superficial femoral artery
11 Left distal superficial femoral artery
12 Right popliteal artery
13 Left popliteal artery
14 Right tibiofibular tract
15 Left tibiofibular tract
16 Right proximal anterior tibial artery
17 Left proximal anterior tibial artery
18 Right distal anterior tibial artery
19 Left distal anterior tibial artery
20 Right proximal posterior tibial artery
21 Left proximal posterior tibial artery
22 Right distal posterior tibial artery
23 Left distal posterior tibial artery
24 Right proximal fibular artery
25 Left proximal fibular artery
26 Right distal fibular artery
27 Left distal fibular artery
FIGURE 2: 85 year-old-male patient with known PAD. (a) MIP/MPR of subtracted TWIST images of entire lower extremities reveal
multiple significant artery stenoses and occlusions on both lower legs, with a severe stenosis of the right posterior tibial artery
(arrow) accompanied by intact perfusion of the distal vessel segments. (b–f) Dynamic image analysis of the right lower leg however
reveal a total occlusion of the right posterior tibial artery, with retrograde perfusion by a distally located small collateral artery
between the right distal fibular artery and the right distal posterior tibial artery (arrow). This finding could only be concluded due to
available dynamic flow information.
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However, dynamic flow comparison of both ipsi- and contra-
lateral adjacent arterial vessel segments yielded sufficient informa-
tion for determination of significant (in-stent) artery stenosis or
occlusions. Clinical examples are provided in Figs. 2 and 3.
Diagnostic Performance
MRA and DSA were available in 256 arterial segments in
16 patients.
In total, 62 significant artery stenoses (11 in pelvic seg-
ments, 23 in thigh segments, and 28 in lower leg segments)
and 27 artery occlusions (1 in pelvic segments, 7 in thigh seg-
ments, and 19 in lower leg segments) were diagnosed at
DSA. Of these, 96.5%–100% (depending on location and
reader) were successfully detected at MRA.
The performance of the three readers for the detection
of hemodynamically relevant stenosis and occlusion is pres-
ented in Tables 4 and 5, respectively.
FIGURE 3: 81 year-old-male patient with symptoms of PAD and severely impaired kidney function. (a) MIP/MPR of subtracted TWIST-
images of the lower extremities show multiple artery occlusion of the lower legs and a severe artery stenosis of the right superficial
femoral artery (arrow). (b) Subtracted dynamic TWIST images and enlarged view (c) of the right femoral artery stenosis (arrow), DSA
was performed afterwards and the severity of the stenosis was confirmed (arrow) (d). Stent-PTA was done for treatment (e). (f)
Subtracted dynamic TWIST-images of both lower legs reveal proximal occlusion of the right anterior (vertical arrow) and posterior
(horizontal arrow) tibial artery, which was confirmed in DSA afterwards (g,h).
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Inter-Reader Agreement
Excellent to almost perfect agreement among readers was
achieved both for detection of significant artery stenosis and
artery occlusion with ICC values >0.90 in every anatomic
vessel region.
Overall comparison showed excellent correlation with
ICC values of 0.95 for significant artery stenosis and 0.98
for artery occlusion. Moreover, ICC values were calculated
for every anatomic station (pelvic, thigh, and lower leg sta-
tion) yielding comparable values (ICC 0.98, 0.96, and
0.91 for significant artery stenosis and ICC 1.0, 1.0, and
0.98 for artery occlusion).
Venous Overlay
No notable venous overlay (grade 2) leading to a loss of
diagnostic—accuracy was observed in any artery segment in
any of the 40 patients.
Mild venous overlay (grade 1) was noted in a total of
7 of 40 patients (17.5%); 3 artery segments in the pelvic
region, 5 artery segments in the thigh region, and 12 artery
segments in the lower leg region.
In 33 out of 40 patients (82.5%), no venous overlay
(grade 0) was observed.
Mean values and standard deviation for grading of
venous overlay ranged from 0.11  0.37 in the pelvic region
to 0.28  0.45 in the lower leg region (see Fig. 4).
TABLE 4. Comparison of TWIST-MRA With DSA for the Detection of Significant Artery Stenosis
Reader and Statistic
Overall
Performance (n = 256) Pelvis (n = 61) Thigh (n = 85)
Lower
Legs (n = 110)
Reader 1
Sensitivity (%) 95.1 (86.3–99) 100 (71.5–100) 95.5 (77.2–99.9) 92.9 (81.7–99.9)
Specificity (%) 98 (94.8–99.4) 98 (89.4–99.9) 96.8 (89–99.6) 98.8 (93.4–99.9)
Positive predictive value
(%)
93.6 (84.6–97.5) 91.7 (61.2–98.7) 91.3 (72.8–97.6) 96.4 (79.4–99.5)
Negative predictive
value (%)
98.5 (95.5–99.5) 100 (N.A.) 98.4 (90–99.8) 98.8 (92.2–99.8)
Accuracy (%) 97.3 (94.5–98.9) 98.4 (91.2–99.9) 96.5 (90–99.3) 98.2 (93.6–99.8)
Reader 2
Sensitivity (%) 96.8 (88.8–99.6) 100 (71.5–100) 95.7 (78.05–
99.9)
96.4 (81.7–99.9)
Specificity (%) 98.5 (95.6–99.7) 100 (92.9–100) 98.4 (91.3–99.9) 98. 8 (93.4–99.9)
Positive predictive value
(%)
95.2 (86.7–98.4) 100 (N.A.) 95.7 (75.9–99.4) 96.4 (79.4–99.5)
Negative predictive
value (%)
99 (96.1–99.7) 100 (N.A.) 98.4 (90–99.8) 98.8 (92.2–99.8)
Accuracy (%) 98.1 (95.5–99.4) 100 (94.1–100) 97.7 (91.8–99.7) 98.2 (93.6–99.8)
Reader 3
Sensitivity (%) 96.7 (88.7–99.7) 100 (71.5–100) 95.5 (77.2–99.9) 96.4 (81.7–99.9)
Specificity (%) 98.5 (95.6–99.7) 100 (92.9–100) 98.3 (91.1–99.9) 97.6 (91.5–99.7)
Positive predictive value
(%)
95.2 (86.5–98.4) 100 (N.A.) 93.6 (84.6–97.5) 93.1 (77.4–98.2)
Negative predictive
value (%)
98.9 (96.1–99.7) 100 (N.A.) 98.3 (89.7–99.8) 98.8 (92.1–99.8)
Accuracy (%) 98.1 (95.5–99.4) 100 (94.1–100) 97.6 (91.5–99.7) 97.3 (92.2–99.4)
DSA (stenoses) n = 62 n = 11 n = 23 n = 28
Data in parentheses are 95%-confidence intervals, n = number of correlated artery segments; N.A. = Not Applicable.
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Intraclass correlation coefficients revealed a good overall
correlation with ICC values of 0.81 (pelvic region 0.85; thigh
region 0.84; and lower leg region 0.77).
ANOVA revealed no statistically significant differences
between readers with regard to grading of venous overlay
(overall grades P = 0.88; pelvic region P = 0.97; thigh region
P = 0.92; and lower leg region P = 0.87).
Image Quality
Analysis of overall image quality yielded good to excellent rat-
ings for all readers (3.41  0.72, 3.33  0.65, and
3.38  0.61 for readers 1, 2, and 3 respectively). A nonsignif-
icant (P = 0.18) decrease in image quality from the pelvic to
the lower leg arteries was noted, due to decreasing vessel size
as well as increasing occurrence of collateral artery vessels in
PAD (pelvic region 3.69  0.63/3.61  0.65/3.54  0.51;
thigh region 3.44  0.73/3.31  0.70/3.38  0.62; and
lower leg region 3.22  .075/3.18  0.59/3.27  0.63).
There were no patients in which image quality was consid-
ered nondiagnostic (Fig. 5).
Intraclass correlation coefficients revealed a good
overall correlation with ICC values of 0.75 between readers
(pelvic region 0.77; thigh region 0.71; and lower leg
region 0.71).
ANOVA revealed no statistically significant differ-
ences between readers (overall rating P = 0.47; pelvic
region P = 0.93; thigh region P = 0.87; and lower leg
region P = 0.18).
TABLE 5. Comparison of TWIST-MRA With DSA for the Detection of Artery Occlusions
Reader and Statistic
Overall
Performance (n = 256) Pelvis (n = 61) Thigh (n = 85)
Lower
Legs (n = 110)
Reader 1
Sensitivity (%) 100 (87.2–100) 100 (2.5–100) 100 (59.1–100) 100 (82.4–100)
Specificity (%) 99.1 (96.9–99.9) 100 (94.1–100) 100 (95.4–100) 97.8 (92.4–99.7)
Positive predictive value
(%)
93.1 (77.3–98.2) 100 (N.A.) 100 (N.A.) 90.5 (70.7–97.4)
Negative predictive value
(%)
100 (N.A.) 100 (N.A.) 100 (N.A.) 100 (N.A.)
Accuracy (%) 99.2 (97.2–99.9) 100 (94.1–100) 100 (95.8–100) 98.2 (93.6–99.8)
Reader 2
Sensitivity (%) 100 (87.7–100) 100 (2.5–100) 100 (59.1–100) 100 (82.4–100)
Specificity (%) 99.5 (97.6–99.9) 100 (94.1–100) 100 (95.4–100) 98.9 (94.1–100)
Positive predictive value
(%)
97.6 (80–99.5) 100 (N.A.) 100 (N.A.) 95 (73.1–99.3)
Negative predictive value
(%)
100 (N.A.) 100 (N.A.) 100 (N.A.) 100 (N.A.)
Accuracy (%) 99.6 (97.8–99.9) 100 (94.1–100) 100 (95.8–100) 99.1 (95.1–100)
Reader 3
Sensitivity (%) 100 (87.7–100) 100 (2.5–100) 100 (59.1–100) 100 (82.4–100)
Specificity (%) 99.5 (97.6–99.9) 100 (94.1–100) 100 (95.4–100) 97.8 (92.4–99.7)
Positive predictive value
(%)
97.6 (80–99.5) 100 (N.A.) 100 (N.A.) 90.5 (70.7–97.4)
Negative predictive value
(%)
100 (N.A.) 100 (N.A.) 100 (N.A.) 100 (N.A.)
Accuracy (%) 99.6 (97.8–99.9) 100 (94.1–100) 100 (95.8–100) 98.2 (93.6–99.8)
DSA (occlusion) n = 27 n = 1 n = 7 n = 19
Data in parentheses are 95%-confidence intervals, n = number of artery segments/artery occlusions, N.A. = not applicable.
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DS Evaluation
Average DS was evaluated for the correlated pelvic and thigh
artery segments (n = 34). Due to small vessel caliber and
acquired spatial resolution, infrapopliteal arteries could not be
reliably evaluated with regard to DS quantification.
DS results were 3.08  0.76 mm (mean  SD) for
DSA and 3.35  0.64 mm (mean  SD) for MRA, with
only small differences of means (also see Fig. 6, Bland–
Altman comparison).
ICC values showed good to excellent correlation
between readers with 0.91 [95% CI: 0.57–0.97].
AUC of ROC curve analysis was 0.976 [95 %CI:
0.953–0.993) for reader 1; 0.965 [95% CI 0.935–0.984] for
reader 2; and 0.96 [95%CI: 0.928–0.980] for reader 3 (see
Fig. 7). No statistically significant differences between AUCs
were noted by the DeLong comparison method (P = 0.66,
P = 0.34, P = 0.21).
Discussion
The past 15 years has seen nephrogenic systemic fibrosis
(NSF) and, more recently, gadolinium retention in the brain
as potential problems associated with the administration of
GBCAs. Although NSF now appears to be a problem of the
past with no clear unconfounded cases reported over the past
decade,28 Gd retention is an ongoing concern with all cur-
rently FDA-approved GBCAs shown to be retained in human
tissues to some extent (either as intact molecule or dissociated
Gd bound to macromolecules).17,18 Given concern over
potential, as yet unidentified, health issues associated with
long-term Gd retention in the brain, focus has turned toward
the development of low GBCA dose MRI techniques.29–32
FIGURE 5: Scatter plots of image quality. Each spot represents a
quality rating of each patient in a respective anatomic region. The
vertical lines represent standard deviation with mean indicated as
a thick horizontal line. ICC, intraclass correlation coefficient.
FIGURE 6: Bland–Altman comparison of average diameter
stenosis (DS) in mm for iliac and femoropopliteal artery
segments. Differences of means are plotted against the mean of
MRA and DSA. SD = standard deviation.
FIGURE 7: ROC curves of average DS values for >50% MRA
stenosis R = reader (n = 3)
FIGURE 4: Scatter plots of venous overlay. Each spot represents
a grade of each patient in a respective anatomic region. The
vertical lines represent standard deviation with mean indicated
as a thick horizontal line. ICC, intraclass correlation coefficient.
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In patients suffering from PAD, dynamic MRA tech-
niques including TWIST-MRA are particularly promising for
the assessment of peripheral arteries as they provide functional
information on inflow and outflow dynamics as well as infor-
mation on vessel morphology.12,13,15 However, achieving an
adequate balance between temporal and spatial resolution
while maintaining sufficiently high image quality across the
entire peripheral vascular system from the pelvic to the lower
leg region is still challenging and until recently, only feasible
with the application of relatively large amounts of GBCA. In
abdominal imaging, well-implemented dynamic MRI-
sequences such as GRASP and compressed sensing techniques
yield sufficient temporal and spatial resolutions in smaller
anatomic areas (i.e., specific organs or lesions) such that lower
GBCA doses of 0.05 mmol/kg bodyweight.33,34
A recent study by Kinner et al16 evaluated the feasibility
of using only dynamic flow images of the entire peripheral
vascular system for the detection of peripheral artery stenosis
and occlusion. Although they showed good correlation
between MRA and DSA, the study lacked a dedicated diag-
nostic performance evaluation. Moreover, the signal-to-noise
ratio in the study was low, which was ascribed in part to the
1.5 T magnetic field strength at which examinations were
performed. Notably, however, relatively large amounts of
GBCA were applied (15 mL of gadobutrol, 1.0 M, which
corresponds to 30 mL of a standard 0.5 M GBCA formula-
tion). As noted by the authors, this dose exceeded the stan-
dard dose used at that time (2012) for established,
conventional MRA hybrid protocols, and is today two times
higher than the currently recommended dose of gadobutrol.35
It also goes against current recommenadations to use the low-
est diagnostic dose of GBCA possible.36
In our study, a much lower amount of GBCA (total of
9 mL, 0.5 M gadoteridol) was administered per patient,
corresponding to 0.05–0.06 mmol/kg bodyweight. This is
the lowest dose reported for a diagnostic contrast-enhanced
MRA protocol of the entire lower extremities, with the excep-
tion of unenhanced MRA such as QISS-sequence protocols
and pedal MRA protocols, limited only to the lower leg
regions.8–10,37 However, assessment of dynamic flow informa-
tion does not only represent a “nice-to-have” feature, it more
importantly also yields highly relevant information on vessel
patency with regard to reversed perfusion or hemodynamic
differences between adjacent peripheral arteries, thus provid-
ing a feature which no unenhanced MRA protocol can
provide.
In this study, evaluation of diagnostic performance
resulted in at least comparable sensitivity, specificity and over-
all diagnostic accuracy as previously published studies8,10,15,38
. Sensitivity for detecting significant artery stenosis was
95.1%, exceeding the previously published values of 88%–
91% in ce-MRA. One unenhanced MRA study showed a
higher sensitivity in the detection of significant artery stenosis
(100%), but the corresponding specificity was diminished
dramatically (76.5%), thus compromising overall diagnostic
performance compared to ce-MRA protocols.10
In our study, overall specificity ranged from 97.6% to
98.5% for significant artery stenosis, surpassing values in the
current literature which range from 87.4% to 96.8% in both
ce-MRA and unenhanced MRA protocols.15,39,40
These previously published studies did not report the
diagnostic performance for the detection of peripheral artery
occlusion which in our study, was detected with near perfect
sensitivity and specificity.
Overall diagnostic accuracy for the detection of artery
stenosis in previously published literature has not exceeded
95%.8,10,15,38 Our results, in contrast, showed values ranging
from 96.5% to 100%.
A highly likely explanation for these apparently improved
results lies in the dynamic image analysis available to assist grad-
ing the severity of stenosis, not only by vessel diameter but also
by side-by-side comparison of inflow and outflow dynamics.
This appears to have been especially helpful for the very small
vessel diameters of the lower legs, where it is almost impossible
to reliably measure the degree of stenosis by reduction in vessel
width or caliber. Detection of severely impeded inflow and out-
flow, particularly with the help of contra-lateral flow compari-
sons, was considered to be straight forward by both readers,
highly improving diagnostic confidence in the detection of sig-
nificant stenosis in the lower legs and contributing to the high
diagnostic accuracy reported in our results. Moreover, DSA also
relies on the very same approach, combining morphological and
dynamic impressions, to reach a diagnosis.
Comparison of diagnostic performance across readers
revealed excellent to perfect correlation throughout, even
though the readers had different levels of experience in
assessing MR images. This observation implies that the MRA
technique is reliable, accurate, and comparatively easy to eval-
uate even by junior readers with relatively low levels of radio-
logical practice and experience.
Image quality analysis revealed good to excellent results
in all patients and across both readers, with no segments
deemed nondiagnostic. Similar findings were reported for
evaluation of venous overlay, with none to only slight venous
overlay noted in some segments that did not impair diagnos-
tic confidence. In fact, significant venous overlay rating even
in patients with strong vessel collateralization did not occur
due to the availability of early to late dynamic contrast filling
of each vessel in all anatomic areas, thus always providing full
presentation of even small arteries before the appearance of
contrast-enhanced veins in the same area.
These findings highlight a clear advantage over other
MRA techniques, where both lack of image quality and—
particularly in unenhanced MRA protocols—venous overlay
in lower leg regions negatively affected results in diagnostic
performance.10,39
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Additionally, by only evaluating subtracted, dynamic
MIP images of 4D MRA, the overall workload for image
analysis was reduced, thus saving time in diagnosing PAD.
Analysis of all original source images from the full 4D
dynamic MRA protocol would have been much more time-
consuming although this was not evaluated formally in this
study.
Limitations
First, retrospective studies are, by design and definition,
prone to bias, thus our results need to be confirmed in larger,
prospective trials. Furthermore, in our study, only a relatively
small number of vessel segments could be correlated with
DSA and subsequently evaluated for diagnostic performance.
This was mainly because of the limited necessity to perform
interventional DSA, which can be ascribed to the adequate
image quality of our TWIST-MRA protocol, which in turn
made pure diagnostic DSA obsolete.
Second, our MRA protocol demands a relatively large
number of acquired images per patient. Consequently, fast
dataset reconstruction is a challenging demand on computer
hardware. However, improvements in computer hardware are
common and still ongoing, therefore providing fast recon-
struction options at almost every work station in modern
radiology.
Finally, further studies are needed to evaluate the time
savings achieved by performing diagnoses from MIPs rather
than from original source images.
Conclusion
Our study demonstrates the clinical feasibility and high diag-
nostic accuracy of a dynamic MRA protocol for the depiction
of the entire runoff vasculature using a lower total gadolinium
dose, providing dynamic flow information in every artery seg-
ment. Moreover, this was achieved by reviewing a limited
number of MIP images, and the original source data in case
of questionable pathological findings, thereby potentially
reducing analysis time.
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